These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Rhodium(II) Proximity-Labeling Identifies a Novel Target Site on STAT3 for Inhibitors with Potent Anti-Leukemia Activity. Minus MB; Liu W; Vohidov F; Kasembeli MM; Long X; Krueger MJ; Stevens A; Kolosov MI; Tweardy DJ; Sison EA; Redell MS; Ball ZT Angew Chem Int Ed Engl; 2015 Oct; 54(44):13085-9. PubMed ID: 26480340 [TBL] [Abstract][Full Text] [Related]
4. 3EZ,20Ac-ingenol, a catalytic inhibitor of topoisomerases, downregulates p-Akt and induces DSBs and apoptosis of DT40 cells. Fukuda Y; Kanbe M; Watanabe M; Dan K; Matsuzaki K; Kitanaka S; Miyata S Arch Pharm Res; 2013 Aug; 36(8):1029-38. PubMed ID: 23595550 [TBL] [Abstract][Full Text] [Related]
5. An integrated Drosophila model system reveals unique properties for F14512, a novel polyamine-containing anticancer drug that targets topoisomerase II. Chelouah S; Monod-Wissler C; Bailly C; Barret JM; Guilbaud N; Vispé S; Käs E PLoS One; 2011; 6(8):e23597. PubMed ID: 21853156 [TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone suppresses osteoblast apoptosis by augmenting DNA repair. Schnoke M; Midura SB; Midura RJ Bone; 2009 Sep; 45(3):590-602. PubMed ID: 19450716 [TBL] [Abstract][Full Text] [Related]
7. [Cytotoxic mechanism and antineoplastic action of etoposide]. Dołega A Postepy Hig Med Dosw; 1998; 52(1):67-87. PubMed ID: 9608232 [TBL] [Abstract][Full Text] [Related]
8. Apoptosis induced by DNA topoisomerase I and II inhibitors in human leukemic HL-60 cells. Solary E; Bertrand R; Pommier Y Leuk Lymphoma; 1994 Sep; 15(1-2):21-32. PubMed ID: 7858500 [TBL] [Abstract][Full Text] [Related]
9. Decreased nucleotide excision repair activity and alterations of topoisomerase IIalpha are associated with the in vivo resistance of a P388 leukemia subline to F11782, a novel catalytic inhibitor of topoisomerases I and II. Kruczynski A; Barret JM; Van Hille B; Chansard N; Astruc J; Menon Y; Duchier C; Créancier L; Hill BT Clin Cancer Res; 2004 May; 10(9):3156-68. PubMed ID: 15131057 [TBL] [Abstract][Full Text] [Related]
10. DNA topoisomerase II inhibition by peroxisomicine A(1) and its radical metabolite induces apoptotic cell death of HL-60 and HL-60/MX2 human leukemia cells. Lansiaux A; Laine W; Baldeyrou B; Mahieu C; Wattez N; Vezin H; Martinez FJ; Piñeyro A; Bailly C Chem Res Toxicol; 2001 Jan; 14(1):16-24. PubMed ID: 11170504 [TBL] [Abstract][Full Text] [Related]
11. Ex vivo effects of the dual topoisomerase inhibitor tafluposide (F 11782) on cells isolated from fresh tumor samples taken from patients with cancer. Sargent JM; Elgie AW; Williamson CJ; Hill BT Anticancer Drugs; 2003 Jul; 14(6):467-73. PubMed ID: 12853890 [TBL] [Abstract][Full Text] [Related]
12. F 11782, a dual inhibitor of topoisomerases I and II with an original mechanism of action in vitro, and markedly superior in vivo antitumour activity, relative to three other dual topoisomerase inhibitors, intoplicin, aclarubicin and TAS-103. Etiévant C; Kruczynski A; Barret JM; Perrin D; van Hille B; Guminski Y; Hill BT Cancer Chemother Pharmacol; 2000; 46(2):101-13. PubMed ID: 10972479 [TBL] [Abstract][Full Text] [Related]
13. Relationship between cell cycle changes and variations of the mitochondrial membrane potential induced by etoposide. Facompré M; Wattez N; Kluza J; Lansiaux A; Bailly C Mol Cell Biol Res Commun; 2000 Jul; 4(1):37-42. PubMed ID: 11152626 [TBL] [Abstract][Full Text] [Related]
14. Relationships between DNA strand breakage and apoptotic progression upon treatment of HL-60 leukemia cells with tafluposide or etoposide. Kluza J; Mazinghien R; Irwin H; Hartley JA; Bailly C Anticancer Drugs; 2006 Feb; 17(2):155-64. PubMed ID: 16428933 [TBL] [Abstract][Full Text] [Related]